Jack Nathan Medical Corp.
JNHMF
$0.0036
-$0.0001-2.70%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.53M | 3.84M | 3.94M | 3.89M | -5.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.53M | 3.84M | 3.94M | 3.89M | -5.01M |
| Cost of Revenue | -1.44M | 705.00K | 839.40K | 841.10K | -1.21M |
| Gross Profit | -4.09M | 3.14M | 3.10M | 3.05M | -3.80M |
| SG&A Expenses | -5.10M | 3.84M | 4.06M | 3.98M | -3.71M |
| Depreciation & Amortization | -524.10K | 233.90K | 242.20K | 243.40K | -423.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.07M | 4.78M | 5.14M | 5.06M | -5.35M |
| Operating Income | 1.54M | -931.00K | -1.20M | -1.17M | 332.20K |
| Income Before Tax | 2.67M | -1.32M | -1.70M | -1.43M | 1.64M |
| Income Tax Expenses | -65.30K | -- | -- | -14.50K | -- |
| Earnings from Continuing Operations | 2.73M | -1.32M | -1.70M | -1.42M | 2.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.77M | -1.32M | -1.70M | -1.42M | -1.69M |
| EBIT | 1.54M | -931.00K | -1.20M | -1.17M | 332.20K |
| EBITDA | 1.59M | -748.70K | -1.02M | -984.70K | 508.10K |
| EPS Basic | 0.11 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.02 | -0.01 | -0.01 | -0.01 | 0.01 |
| EPS Diluted | 0.11 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.02 | -0.01 | -0.01 | -0.01 | 0.01 |
| Average Basic Shares Outstanding | 87.10M | 87.10M | 87.10M | 87.10M | 85.53M |
| Average Diluted Shares Outstanding | 87.43M | 96.10M | 87.10M | 96.10M | 85.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |